Ovarian cancer remains the most lethal gynaecological malignancy with 314 000 cases and
207 000 deaths annually worldwide. Ovarian cancer cases and deaths are predicted to …

This review is based on the recent EUROGIN scientific session:“Assessing risk of cervical
cancer in the post‐vaccination era,” which addressed the demands of cervical intraepithelial …

Tobacco use is a major modifiable risk factor for adverse health outcomes, including cancer,
and elicits profound epigenetic changes thought to be associated with long-term cancer risk …

The difficulty of obtaining samples from certain human tissues has led to efforts to find
accessible sources to analyze molecular markers derived from DNA. In this study, we look …

Background: Endometrial cancer (EC) is the leading gynecological cancer worldwide, yet
current EC screening approaches are not satisfying. The purpose of this retrospective study …

Background Normal cell BRCA1 epimutations have been associated with increased risk of
triple-negative breast cancer (TNBC). However, the fraction of TNBCs that may have BRCA1 …

Somatic TP53 mutations are prevalent in normal tissue but little is known about their
association with cancer risk. Cervical liquid-based cytology (LBC), commonly known as Pap …

High-grade serous ovarian cancer (HGSOC) is the most lethal tumor of the female genital
tract. Despite extensive studies and the identification of some precursor lesions like serous …

Recommendations are graded as per the Royal College of Obstetricians and
Gynaecologists document, Clinical Governance Advice No. 1: Guidance for the …

The incidence of endometrial cancer is rising. Measures to identify women at risk and to
detect endometrial cancer earlier are required to reduce the morbidity triggered by the …